The overall objective of this research is to convert the increasingly concerning CO 2 and renewable H 2 to highly demanded methanol (CH 3 OH), which creates a win− win scenario for simultaneous climate change prevention and sustainable economic development. The key to the success of this targeted CO 2 utilization technology is the development of low-pressure methanol synthesis catalysts (Ni a In b Al/SiO 2 ; a = 0−8.3, b = 0−9.1) by means of a phyllosilicate precursor, allowing for formation of well-dispersed metallic particles with an average diameter of 2.5−3.5 nm. The catalysts were characterized with various methods including ICP-OES, N 2 physisorption, XRD, SEM, TEM, TGA, H 2 TPR, DRIFTS, and XPS. The performances of the Ni a In b Al/SiO 2 catalysts and conventional catalyst were compared under various evaluation temperatures at ambient pressure. It was found that catalysts with Ni/In ratios of 0.4−0.7 showed the highest activity. Ni 3.5 In 5.3 Al/SiO 2 (NIA-0.7) with 15% metal loading was the best among the tested Ni a In b Al/SiO 2 catalysts with an activity of 0.33 mol h −1 (mol catalyst metal) −1 in comparison to the benchmark Cu/ZnO/ Al 2 O 3 (CZA) catalyst at 0.17. Several Ni a In b Al/SiO 2 catalysts also showed similar CO 2 conversions in comparison to the CZA catalyst. Infrared studies using DRIFTS determined that CO 2 hydrogenation on Ni a In b Al/SiO 2 catalysts proceeds through monodentate carbonate before further conversion to monodentate and bidentate formate. With a feed of CO/H 2 instead of CO 2 /H 2 the primary hydrocarbon product changes from methanol to propane, accompanied by a lack of formate and monodentate carbonate IR signals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.